Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Shares Outstanding for 4 consecutive years, with $61.8 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Shares Outstanding rose 64.26% year-over-year to $61.8 million, compared with a TTM value of $61.8 million through Sep 2023, up 64.26%, and an annual FY2022 reading of $53.7 million, up 112.6% over the prior year.
  • Shares Outstanding was $61.8 million for Q3 2023 at Terns Pharmaceuticals, up from $61.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $61.8 million in Q3 2023 and bottomed at $215890.0 in Q1 2020.
  • Average Shares Outstanding over 4 years is $28.2 million, with a median of $25.3 million recorded in 2021.
  • The sharpest move saw Shares Outstanding surged 11499.3% in 2021, then rose 0.91% in 2022.
  • Year by year, Shares Outstanding stood at $337508.0 in 2020, then soared by 7387.01% to $25.3 million in 2021, then skyrocketed by 112.6% to $53.7 million in 2022, then grew by 15.01% to $61.8 million in 2023.
  • Business Quant data shows Shares Outstanding for TERN at $61.8 million in Q3 2023, $61.1 million in Q2 2023, and $56.7 million in Q1 2023.